ACM
TECH icon

American Capital Management’s Bio-Techne TECH Stock Holding History

American Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.4M Buy
1,021,128
+79,979
+8% +$4.8M 2.87% 11
2025
Q4 		$55.3M Sell
941,149
-19,298
-2% -$1.17M 2.44% 14
2025
Q3 		$53.4M Buy
960,447
+8,833
+0.9% +$473K 2.13% 18
2025
Q2 		$49M Sell
951,614
-174,034
-15% -$8.74M 2.03% 22
2025
Q1 		$66M Buy
1,125,648
+61,782
+6% +$4.19M 2.69% 17
2024
Q4 		$76.6M Sell
1,063,866
-50,527
-5% -$3.71M 2.85% 11
2024
Q3 		$89.1M Buy
1,114,393
+27,508
+3% +$2.07M 2.91% 10
2024
Q2 		$77.9M Buy
1,086,885
+70,329
+7% +$5.18M 2.61% 14
2024
Q1 		$71.6M Buy
1,016,556
+56,464
+6% +$4.04M 2.29% 18
2023
Q4 		$74.1M Buy
960,092
+39,393
+4% +$2.59M 2.53% 15
2023
Q3 		$62.7M Buy
920,699
+20,191
+2% +$1.6M 2.42% 18
2023
Q2 		$73.5M Buy
900,508
+13,681
+2% +$1.1M 2.55% 16
2023
Q1 		$65.8M Buy
886,827
+20,227
+2% +$1.56M 2.32% 16
2022
Q4 		$71.8M Buy
866,600
+101,616
+13% +$8.07M 2.81% 14
2022
Q3 		$54.3M Sell
764,984
-8,936
-1% -$772K 2.14% 20
2022
Q2 		$67.1M Buy
773,920
+2,828
+0.4% +$265K 2.51% 17
2022
Q1 		$83.5M Buy
771,092
+11,968
+2% +$1.23M 2.46% 17
2021
Q4 		$98.2M Sell
759,124
-4,628
-0.6% -$567K 2.52% 12
2021
Q3 		$92.5M Buy
763,752
+3,020
+0.4% +$368K 2.48% 15
2021
Q2 		$85.6M Buy
760,732
+10,344
+1% +$1.09M 2.4% 14
2021
Q1 		$71.6M Buy
750,388
+2,868
+0.4% +$262K 2.17% 15
2020
Q4 		$59.3M Sell
747,520
-5,244
-0.7% -$380K 1.77% 23
2020
Q3 		$46.6M Sell
752,764
-5,136
-0.7% -$334K 1.71% 24
2020
Q2 		$50M Buy
757,900
+19,876
+3% +$1.19M 1.84% 22
2020
Q1 		$35M Buy
738,024
+311,364
+73% +$15.6M 1.7% 24
2019
Q4 		$23.4M Buy
426,660
+5,480
+1% +$288K 0.98% 32
2019
Q3 		$20.6M Sell
421,180
-812
-0.2% -$40.7K 0.91% 34
2019
Q2 		$22M Buy
421,992
+2,412
+0.6% +$122K 0.94% 32
2019
Q1 		$20.8M Buy
419,580
+15,320
+4% +$689K 0.97% 34
2018
Q4 		$14.6M Buy
404,260
+317,248
+365% +$13.3M 0.78% 39
2018
Q3 		$4.44M Buy
87,012
+440
+0.5% +$19.5K 0.19% 54
2018
Q2 		$3.2M Buy
86,572
+400
+0.5% +$15.3K 0.17% 57
2018
Q1 		$3.25M Buy
86,172
+41,600
+93% +$1.47M 0.19% 55
2017
Q4 		$1.44M Buy
44,572
+6,160
+16% +$196K 0.09% 64
2017
Q3 		$1.16M Buy
38,412
+412
+1% +$12.2K 0.07% 65
2017
Q2 		$1.12M Buy
38,000
+860
+2% +$23.5K 0.07% 69
2017
Q1 		$944K Buy
37,140
+3,280
+10% +$84.7K 0.07% 73
2016
Q4 		$870K Buy
33,860
+1,760
+5% +$46.2K 0.07% 78
2016
Q3 		$879K Buy
32,100
+640
+2% +$17.6K 0.07% 78
2016
Q2 		$887K Buy
31,460
+1,240
+4% +$31.9K 0.07% 85
2016
Q1 		$714K Buy
30,220
+9,880
+49% +$218K 0.06% 87
2015
Q4 		$458K Buy
20,340
+4,040
+25% +$92.1K 0.04% 89
2015
Q3 		$377K Sell
16,300
-400
-2% -$10K 0.04% 65
2015
Q2 		$411K Buy
16,700
+2,600
+18% +$64.9K 0.04% 67
2015
Q1 		$354K Sell
14,100
-2,600
-16% -$61.8K 0.03% 67
2014
Q4 		$386K Buy
16,700
+5,900
+55% +$135K 0.04% 69
2014
Q3 		$253K Hold
10,800
– – 0.03% 75
2014
Q2 		$250K Buy
10,800
+1,000
+10% +$22.1K 0.03% 77
2014
Q1 		$209K Buy
+9,800
New +$221K 0.02% 77

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Capital Management's TECH Position: Q1 2026 in Review

American Capital Management increased its Bio-Techne (TECH) stake by 8.5% in Q1 2026, buying an estimated $4.8M and bringing the position to 1,021,128 shares worth $53.4M. The position accounts for 2.87% of the portfolio, ranked #11.

American Capital Management first reported a position in TECH in Q1 2014 and has held it in 49 quarters since. The position peaked at $98.2M in Q4 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • American Capital Management held 1,021,128 shares of Bio-Techne worth $53.4M as of Q1 2026.
  • American Capital Management bought 79,979 Bio-Techne shares in Q1 2026, an estimated $4.8M.
  • Bio-Techne made up 2.87% of American Capital Management's portfolio in Q1 2026, its #11 holding.
  • American Capital Management first reported a position in Bio-Techne in Q1 2014 and has held it in 49 quarters since.
  • American Capital Management's Bio-Techne position peaked at $98.2M in Q4 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on American Capital Management's 13F filing for Q1 2026, filed 15 May 2026.